USD635241S1 - Dry powder inhaler - Google Patents

Dry powder inhaler Download PDF

Info

Publication number
USD635241S1
USD635241S1 US29/319,775 US31977508F USD635241S US D635241 S1 USD635241 S1 US D635241S1 US 31977508 F US31977508 F US 31977508F US D635241 S USD635241 S US D635241S
Authority
US
United States
Prior art keywords
dry powder
powder inhaler
view
inhaler
dry
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
US29/319,775
Inventor
Scott McLean
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mannkind Corp
Original Assignee
Mannkind Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mannkind Corp filed Critical Mannkind Corp
Priority to US29/319,775 priority Critical patent/USD635241S1/en
Assigned to MANNKIND CORPORATION reassignment MANNKIND CORPORATION ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: MCLEAN, SCOTT
Priority to CA 128911 priority patent/CA128911S/en
Application granted granted Critical
Publication of USD635241S1 publication Critical patent/USD635241S1/en
Assigned to DEERFIELD PRIVATE DESIGN FUND II, L.P., DEERFIELD PRIVATE DESIGN INTERNATIONAL II, L.P., HORIZON SANTE FLML SARL reassignment DEERFIELD PRIVATE DESIGN FUND II, L.P. SECURITY AGREEMENT Assignors: MANNKIND CORPORATION
Assigned to AVENTISUB LLC reassignment AVENTISUB LLC PATENT SECURITY AGREEMENT Assignors: MANNKIND CORPORATION
Assigned to MANNKIND CORPORATION reassignment MANNKIND CORPORATION RELEASE BY SECURED PARTY (SEE DOCUMENT FOR DETAILS). Assignors: AVENTISUB LLC
Assigned to MANNKIND CORPORATION reassignment MANNKIND CORPORATION RELEASE BY SECURED PARTY (SEE DOCUMENT FOR DETAILS). Assignors: DEERFIELD PRIVATE DESIGN FUND II, L.P., DEERFIELD PRIVATE DESIGN INTERNATIONAL II, L.P., HORIZON SANTE FLML SARL
Assigned to MIDCAP FINANCIAL TRUST, AS AGENT reassignment MIDCAP FINANCIAL TRUST, AS AGENT SECURITY INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: MANNKIND CORPORATION, MANNKIND LLC
Assigned to MANNKIND CORPORATION, MANNKIND LLC reassignment MANNKIND CORPORATION RELEASE BY SECURED PARTY (SEE DOCUMENT FOR DETAILS). Assignors: MIDCAP FINANCIAL TRUST, AS AGENT
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Description

FIG. 1 is a top view of a dry powder inhaler in a closed position.
FIG. 2 is a perspective view of the dry powder inhaler of FIG. 1 in a mid-longitudinal section.
FIG. 3 is a bottom view of the dry powder inhaler of FIG. 1.
FIG. 4 is side view of the dry powder inhaler in FIG. 1.
FIG. 5 is mid-longitudinal section view of the dry powder inhaler in FIG. 1 in a partially opened position.
FIG. 6 is another perspective side view of the dry powder inhaler shown in FIG. 1; and,
FIG. 7 is another perspective view of the dry powder inhaler shown in FIG. 1.
The broken lines in FIGS. 1, 3, 4, and 5 are included for the purpose of illustrating environmental structures and form no part of the claimed design.

Claims (1)

  1. The ornamental design for a dry powder inhaler, as shown and described.
US29/319,775 2008-06-13 2008-06-13 Dry powder inhaler Active USD635241S1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US29/319,775 USD635241S1 (en) 2008-06-13 2008-06-13 Dry powder inhaler
CA 128911 CA128911S (en) 2008-06-13 2008-12-10 Dry powder inhaler

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US29/319,775 USD635241S1 (en) 2008-06-13 2008-06-13 Dry powder inhaler

Publications (1)

Publication Number Publication Date
USD635241S1 true USD635241S1 (en) 2011-03-29

Family

ID=43770345

Family Applications (1)

Application Number Title Priority Date Filing Date
US29/319,775 Active USD635241S1 (en) 2008-06-13 2008-06-13 Dry powder inhaler

Country Status (2)

Country Link
US (1) USD635241S1 (en)
CA (1) CA128911S (en)

Cited By (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9192675B2 (en) 2008-06-13 2015-11-24 Mankind Corporation Dry powder inhaler and system for drug delivery
US9220687B2 (en) 2008-12-29 2015-12-29 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
US9233159B2 (en) 2011-10-24 2016-01-12 Mannkind Corporation Methods and compositions for treating pain
US9241903B2 (en) 2006-02-22 2016-01-26 Mannkind Corporation Method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent
US9283193B2 (en) 2005-09-14 2016-03-15 Mannkind Corporation Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
US9364619B2 (en) 2008-06-20 2016-06-14 Mannkind Corporation Interactive apparatus and method for real-time profiling of inhalation efforts
US9364436B2 (en) 2011-06-17 2016-06-14 Mannkind Corporation High capacity diketopiperazine microparticles and methods
US9630930B2 (en) 2009-06-12 2017-04-25 Mannkind Corporation Diketopiperazine microparticles with defined specific surface areas
US9662461B2 (en) 2008-06-13 2017-05-30 Mannkind Corporation Dry powder drug delivery system and methods
US9675674B2 (en) 2004-08-23 2017-06-13 Mannkind Corporation Diketopiperazine salts for drug delivery and related methods
US9700690B2 (en) 2002-03-20 2017-07-11 Mannkind Corporation Inhalation apparatus
US9706944B2 (en) 2009-11-03 2017-07-18 Mannkind Corporation Apparatus and method for simulating inhalation efforts
US9796688B2 (en) 2004-08-20 2017-10-24 Mannkind Corporation Catalysis of diketopiperazine synthesis
US9801925B2 (en) 1999-06-29 2017-10-31 Mannkind Corporation Potentiation of glucose elimination
US9802012B2 (en) 2012-07-12 2017-10-31 Mannkind Corporation Dry powder drug delivery system and methods
US9925144B2 (en) 2013-07-18 2018-03-27 Mannkind Corporation Heat-stable dry powder pharmaceutical compositions and methods
US9943571B2 (en) 2008-08-11 2018-04-17 Mannkind Corporation Use of ultrarapid acting insulin
US9983108B2 (en) 2009-03-11 2018-05-29 Mannkind Corporation Apparatus, system and method for measuring resistance of an inhaler
USD822827S1 (en) * 2016-10-14 2018-07-10 Hoya Corporation End cap for an endoscope
US10159644B2 (en) 2012-10-26 2018-12-25 Mannkind Corporation Inhalable vaccine compositions and methods
USD837157S1 (en) * 2017-04-11 2019-01-01 Gyrus Acmi, Inc. Plug
US10307464B2 (en) 2014-03-28 2019-06-04 Mannkind Corporation Use of ultrarapid acting insulin
US10342938B2 (en) 2008-06-13 2019-07-09 Mannkind Corporation Dry powder drug delivery system
US10421729B2 (en) 2013-03-15 2019-09-24 Mannkind Corporation Microcrystalline diketopiperazine compositions and methods
US10561806B2 (en) 2014-10-02 2020-02-18 Mannkind Corporation Mouthpiece cover for an inhaler
US10625034B2 (en) 2011-04-01 2020-04-21 Mannkind Corporation Blister package for pharmaceutical cartridges
US11446127B2 (en) 2013-08-05 2022-09-20 Mannkind Corporation Insufflation apparatus and methods
US11478591B2 (en) 2016-05-19 2022-10-25 Mannkind Corporation Apparatus, system and method for detecting and monitoring inhalations
USD1003427S1 (en) * 2020-09-08 2023-10-31 Feather Company Ltd. Inhaler
USD1022193S1 (en) * 2022-01-28 2024-04-09 Straub Medical Ag Catheter head
USD1022191S1 (en) * 2021-05-12 2024-04-09 Straub Medical Ag Catheter head

Cited By (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9801925B2 (en) 1999-06-29 2017-10-31 Mannkind Corporation Potentiation of glucose elimination
US9700690B2 (en) 2002-03-20 2017-07-11 Mannkind Corporation Inhalation apparatus
US9796688B2 (en) 2004-08-20 2017-10-24 Mannkind Corporation Catalysis of diketopiperazine synthesis
US10130685B2 (en) 2004-08-23 2018-11-20 Mannkind Corporation Diketopiperazine salts for drug delivery and related methods
US9675674B2 (en) 2004-08-23 2017-06-13 Mannkind Corporation Diketopiperazine salts for drug delivery and related methods
US9283193B2 (en) 2005-09-14 2016-03-15 Mannkind Corporation Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
US9446001B2 (en) 2005-09-14 2016-09-20 Mannkind Corporation Increasing drug affinity for crystalline microparticle surfaces
US9717689B2 (en) 2005-09-14 2017-08-01 Mannkind Corporation Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
US10143655B2 (en) 2005-09-14 2018-12-04 Mannkind Corporation Method of drug formulation
US9241903B2 (en) 2006-02-22 2016-01-26 Mannkind Corporation Method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent
US10130581B2 (en) 2006-02-22 2018-11-20 Mannkind Corporation Method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent
US9511198B2 (en) 2008-06-13 2016-12-06 Mannkind Corporation Dry powder inhaler and system for drug delivery
US9192675B2 (en) 2008-06-13 2015-11-24 Mankind Corporation Dry powder inhaler and system for drug delivery
US9339615B2 (en) 2008-06-13 2016-05-17 Mannkind Corporation Dry powder inhaler and system for drug delivery
US10342938B2 (en) 2008-06-13 2019-07-09 Mannkind Corporation Dry powder drug delivery system
US9662461B2 (en) 2008-06-13 2017-05-30 Mannkind Corporation Dry powder drug delivery system and methods
US9446133B2 (en) 2008-06-13 2016-09-20 Mannkind Corporation Dry powder inhaler and system for drug delivery
US10751488B2 (en) 2008-06-13 2020-08-25 Mannkind Corporation Dry powder inhaler and system for drug delivery
US10201672B2 (en) 2008-06-13 2019-02-12 Mannkind Corporation Dry powder inhaler and system for drug delivery
US10675421B2 (en) 2008-06-20 2020-06-09 Mannkind Corporation Interactive apparatus and method for real-time profiling of inhalation efforts
US9364619B2 (en) 2008-06-20 2016-06-14 Mannkind Corporation Interactive apparatus and method for real-time profiling of inhalation efforts
US9943571B2 (en) 2008-08-11 2018-04-17 Mannkind Corporation Use of ultrarapid acting insulin
US10172850B2 (en) 2008-12-29 2019-01-08 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
US9655850B2 (en) 2008-12-29 2017-05-23 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
US9220687B2 (en) 2008-12-29 2015-12-29 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
US9983108B2 (en) 2009-03-11 2018-05-29 Mannkind Corporation Apparatus, system and method for measuring resistance of an inhaler
US9630930B2 (en) 2009-06-12 2017-04-25 Mannkind Corporation Diketopiperazine microparticles with defined specific surface areas
US9706944B2 (en) 2009-11-03 2017-07-18 Mannkind Corporation Apparatus and method for simulating inhalation efforts
US10625034B2 (en) 2011-04-01 2020-04-21 Mannkind Corporation Blister package for pharmaceutical cartridges
US9364436B2 (en) 2011-06-17 2016-06-14 Mannkind Corporation High capacity diketopiperazine microparticles and methods
US10130709B2 (en) 2011-06-17 2018-11-20 Mannkind Corporation High capacity diketopiperazine microparticles and methods
US9610351B2 (en) 2011-10-24 2017-04-04 Mannkind Corporation Methods and compositions for treating pain
US10258664B2 (en) 2011-10-24 2019-04-16 Mannkind Corporation Methods and compositions for treating pain
US9233159B2 (en) 2011-10-24 2016-01-12 Mannkind Corporation Methods and compositions for treating pain
US9802012B2 (en) 2012-07-12 2017-10-31 Mannkind Corporation Dry powder drug delivery system and methods
US10159644B2 (en) 2012-10-26 2018-12-25 Mannkind Corporation Inhalable vaccine compositions and methods
US10421729B2 (en) 2013-03-15 2019-09-24 Mannkind Corporation Microcrystalline diketopiperazine compositions and methods
US9925144B2 (en) 2013-07-18 2018-03-27 Mannkind Corporation Heat-stable dry powder pharmaceutical compositions and methods
US11446127B2 (en) 2013-08-05 2022-09-20 Mannkind Corporation Insufflation apparatus and methods
US10307464B2 (en) 2014-03-28 2019-06-04 Mannkind Corporation Use of ultrarapid acting insulin
US10561806B2 (en) 2014-10-02 2020-02-18 Mannkind Corporation Mouthpiece cover for an inhaler
US11478591B2 (en) 2016-05-19 2022-10-25 Mannkind Corporation Apparatus, system and method for detecting and monitoring inhalations
USD822827S1 (en) * 2016-10-14 2018-07-10 Hoya Corporation End cap for an endoscope
USD837157S1 (en) * 2017-04-11 2019-01-01 Gyrus Acmi, Inc. Plug
USD1003427S1 (en) * 2020-09-08 2023-10-31 Feather Company Ltd. Inhaler
USD1022191S1 (en) * 2021-05-12 2024-04-09 Straub Medical Ag Catheter head
USD1022193S1 (en) * 2022-01-28 2024-04-09 Straub Medical Ag Catheter head

Also Published As

Publication number Publication date
CA128911S (en) 2009-11-26

Similar Documents

Publication Publication Date Title
USD635241S1 (en) Dry powder inhaler
USD635242S1 (en) Dry powder inhaler
USD604833S1 (en) Dry powder inhaler
USD590694S1 (en) Closure means
USD580777S1 (en) Aerosol container
USD635243S1 (en) Dry powder inhaler
USD629886S1 (en) Dry powder inhaler
USD629887S1 (en) Dry powder inhaler
USD629888S1 (en) Dry powder inhaler
USD629506S1 (en) Dry powder inhaler
USD629505S1 (en) Dry powder inhaler
USD614760S1 (en) Dry powder inhaler
USD605752S1 (en) Dry powder inhaler
USD623060S1 (en) Bottle closure
USD565427S1 (en) Combined watch and telephone
USD600124S1 (en) Container
USD551324S1 (en) Pot filler
USD603037S1 (en) Gas firepit
USD570688S1 (en) Container
USD645349S1 (en) Container
USD554293S1 (en) Cosmetic case
USD565407S1 (en) Flip top closure
USD575165S1 (en) Novelty container with puppet
USD586342S1 (en) Front cover for a handset
USD594743S1 (en) Box

Legal Events

Date Code Title Description
FEPP Fee payment procedure

Free format text: PAT HOLDER CLAIMS SMALL ENTITY STATUS, ENTITY STATUS SET TO SMALL (ORIGINAL EVENT CODE: LTOS); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY